RE:Question for Eoganacht N0taP00p wrote: You mentioned in a previous post you estimate around 40-50% CR at 450 days eventually. You also mentioned Adstiladrin CR at 450 days is around 24%. How do you reconcile that against the FDA release which states "Overall, 51% of enrolled patients using Adstiladrin therapy achieved a complete response (the disappearance of all signs of cancer as seen on cystoscopy, biopsied tissue, and urine). The median duration of response was 9.7 months. Forty-six percent of responding patients remained in complete response for at least one year". Is 46% CR at 12 months our comparable target? Don't know how to read that. It seems like the FDA is using the 46% CR number. Any clarification appreciated. Thanks in advance.
51% of these patients achieved CR at any time Vs our 65% CR plus 12% iR. Of these 51% Who achieved a CR status, 46% % remained CR for 12 months. 46% of 51% =23.5% overall.